Hot tabletting of slow-release tramadol hydrochloride microcapsules with cores obtained via compaction. 2010

Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
Department of Pharmaceutical Technology, Medical University of Gdańsk, Gdańsk, Poland.

BACKGROUND Coating, as a processing technique, applied to active pharmaceutical ingredient (API) crystals or particles (carriers) with an appropriate polymer allows to obtain a modified-release pharmaceutical dosage form. Such carriers can be the basic ingredient of a multi-unit dosage form. Additionally, coated API crystals (microcapsules) can provide an alternative to spherical granulate (pellets) as the main and most commonly used component of multi-unit dosage forms. Coating individual API crystals is a complicated process because of the crystals having insufficient size (below 100 microm), irregular shape, low mechanical durability and the fact that API crystals dissolve upon contact with the coating mixture, and other factors. METHODS Compaction process was used to eliminate these inconveniences allowing us to obtain tramadol hydrochloride (TH) microcapsule cores in the size range of 212-500 microm. The coating of the cores was successfully conducted using a fluidized-bed coating technique with four different polymers that allowed us to attain slow release of TH. Then, the microcapsules were subjected to a hot tabletting process conducted by applying a low compression force of about 1 kN at 56 degrees C. Semi-liquid granules containing melted PEG 3000 combined with TH microcapsules were compressed. A tablet matrix of good physical parameters was created when its temperature decreased to room temperature. In the proposed hot tabletting method, PEG 3000 included in the granulate provided the tableted microcapsules sufficient protection against rupture. RESULTS The compaction process allowed us to eliminate unwanted physical API properties, which could otherwise have an adverse effect on the fluidized-bed coating process. The microcapsule cores after compaction and coating using a fluidized-bed coating technique showed a TH-release profile similar to that of the compressed microcapsules after applying hot tabletting process. CONCLUSIONS Multi-unit dosage forms can be obtained in a relatively simple way by combining three processes: (i) obtaining TH microcapsule cores by compaction, (ii) coating, and (iii) hot tabletting.

UI MeSH Term Description Entries
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D013678 Technology, Pharmaceutical The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients. Technology, Pharmacy,Pharmaceutic Technology,Pharmaceutical Technology,Pharmacy Technology,Technology, Pharmaceutic
D014147 Tramadol A narcotic analgesic proposed for severe pain. It may be habituating. Adolonta,Amadol,Biodalgic,Biokanol,Contramal,Jutadol,K-315,MTW-Tramadol,Nobligan,Prontofort,Ranitidin 1A Pharma,Takadol,Theradol,Tiral,Topalgic,Tradol,Tradol-Puren,Tradonal,Tralgiol,Trama 1A Pharma,Trama AbZ,Trama KD,Trama-Dorsch,Tramabeta,Tramadin,Tramadoc,Tramadol 1A,Tramadol AL,Tramadol Asta Medica,Tramadol Basics,Tramadol Bayvit,Tramadol Bexal,Tramadol Cinfa,Tramadol Edigen,Tramadol Heumann,Tramadol Hydrochloride,Tramadol Kern,Tramadol Lichtenstein,Tramadol Lindo,Tramadol Mabo,Tramadol Normon,Tramadol PB,Tramadol Ratiopharm,Tramadol Stada,Tramadol acis,Tramadol-Dolgit,Tramadol-Hameln,Tramadol-ratiopharm,Tramadolor,Tramadura,Tramagetic,Tramagit,Tramake,Tramal,Tramex,Tramundin,Trasedal,Ultram,Xymel 50,Zamudol,Zumalgic,Zydol,Zytram,K 315,K315,MTW Tramadol,MTWTramadol,Tradol Puren,TradolPuren,Trama Dorsch,TramaDorsch,Tramadol Dolgit,Tramadol Hameln,TramadolDolgit,TramadolHameln,Tramadolratiopharm

Related Publications

Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
December 1986, Die Pharmazie,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
January 2000, Journal of microencapsulation,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
January 1988, Journal of microencapsulation,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
April 2010, Current drug delivery,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
July 1982, Die Pharmazie,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
May 2018, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
July 2010, Drug delivery,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
May 2005, Journal of controlled release : official journal of the Controlled Release Society,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
December 1998, Journal of colloid and interface science,
Wiesław Sawicki, and Jarosław Mazgalski, and Ilona Jakubowska
September 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Copied contents to your clipboard!